Elanco Animal Health (ELAN) Return on Capital Employed (2018 - 2026)
Elanco Animal Health (ELAN) posted Return on Capital Employed of 5.24% for Q1 2026, up 11.29% sequentially from 4.71% in Q4 2025, and up 1195.0% YoY from 0.4% in Q1 2025.
Elanco Animal Health (ELAN) Return on Capital Employed (2018 - 2026) Analysis & Trends
Elanco Animal Health has reported Return on Capital Employed for 9 years, with the latest figure at 5.24% in Q1 2026.
- Quarterly Return on Capital Employed rose 1195.0% year-over-year to 5.24% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.24% (up 1195.0% YoY) and the FY2025 annual result came in at 4.9%, up 1735.0% from the prior year.
- Return on Capital Employed grew to 5.24% in Q1 2026 per ELAN's latest filing, from 4.71% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 5.24% in Q1 2026 and troughed at 26.01% in Q2 2024.
- A 5-year average of 12.25% and a median of 13.78% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed sank 1255 bps in 2024, then jumped 2580 bps in 2025.
- Over 5 years, Return on Capital Employed stood at 14.68% in 2022, then tumbled by 62 bps to 23.84% in 2023, then soared by 45 bps to 13.02% in 2024, then soared by 136 bps to 4.71% in 2025, then climbed by 11 bps to 5.24% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 5.24%, 4.71%, and 0.41% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | 3.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.52% |
| Mar 31, 2026 | 5.24% |
| Dec 31, 2025 | 4.71% |
| Sep 30, 2025 | 0.41% |
| Jun 30, 2025 | -0.21% |
| Mar 31, 2025 | -6.71% |
| Dec 31, 2024 | -13.02% |
| Sep 30, 2024 | -13.16% |
| Jun 30, 2024 | -26.01% |
| Mar 31, 2024 | -25.03% |
| Dec 31, 2023 | -23.84% |
| Sep 30, 2023 | -21.88% |
| Jun 30, 2023 | -13.46% |
| Mar 31, 2023 | -13.78% |
| Dec 31, 2022 | -14.68% |
| Sep 30, 2022 | -15.25% |
| Jun 30, 2022 | -15.07% |
| Mar 31, 2022 | -16.53% |
| Dec 31, 2021 | -18.15% |
| Sep 30, 2021 | -19.44% |